During the past decade, Chelmsford and Essex Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Chelmsford and Essex Centre" are "Breast Cancer" (2 trials), "Fallopian Tube Cancer" (1 trials), "Ovarian Cancer" (1 trials) and "Primary Peritoneal Cavity Cancer" (1 trials). Many other conditions were trialed in "Chelmsford and Essex Centre" in a lesser frequency.

Most popular intervention types in "Chelmsford and Essex Centre" are "Drug" (3 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "tamoxifen citrate" (2 trials), "Aromatase Inhibitors" (1 trials), "adjuvant therapy" (1 trials), "anastrozole" (1 trials) and "diagnostic laboratory biomarker analysis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chelmsford and Essex Centre" are 3 trials for "Female" genders.

Currently, there are NaN active trials in "Chelmsford and Essex Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Chelmsford and Essex Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chelmsford and Essex Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".